Treating status epilepticus in adults
Tidsskr Nor Laegeforen. 2024 Mar 11;144(4).
doi: 10.4045/tidsskr.23.0782.
Print 2024 Mar 19.
[Article in
English,
Norwegian]
Affiliations
- 1 Nevrologisk avdeling, Oslo universitetssykehus.
- 2 Nevrologisk avdeling, St. Olavs hospital.
- 3 Seksjon for klinisk nevrofysiologi, Oslo universitetssykehus.
- 4 Nevrokirurgisk avdeling, Oslo universitetssykehus.
- 5 Nevrologisk avdeling, Haukeland universitetssjukehus.
- 6 Spesialsykehuset for epilepsi, Oslo universitetssykehus.
- 7 Universitetet i Bergen.
- 8 Nevrologisk avdeling, Oslo universitetssykehus, og, Universitetet i Oslo.
Abstract
This clinical review examines the treatment of status epilepticus, a condition in which epileptic seizures are prolonged and pose a significant risk of brain damage and death. International guidelines recommend the use of benzodiazepines as first-line treatment, and these should be administered promptly and in appropriate doses. Second-line treatment involves the use of high-dose anti-seizure medications to stop and prevent seizures. If seizure activity persists, general anaesthesia should be administered as soon as possible. All neurological hospital departments should have established and rehearsed protocols for treating status epilepticus.
MeSH terms
-
Adult
-
Anticonvulsants / therapeutic use
-
Benzodiazepines / therapeutic use
-
Epilepsy* / drug therapy
-
Humans
-
Status Epilepticus* / drug therapy
-
Status Epilepticus* / prevention & control
Substances
-
Anticonvulsants
-
Benzodiazepines